M. Meurer

3.3k total citations
104 papers, 1.8k citations indexed

About

M. Meurer is a scholar working on Pathology and Forensic Medicine, Dermatology and Epidemiology. According to data from OpenAlex, M. Meurer has authored 104 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Pathology and Forensic Medicine, 35 papers in Dermatology and 28 papers in Epidemiology. Recurrent topics in M. Meurer's work include Systemic Sclerosis and Related Diseases (24 papers), Autoimmune Bullous Skin Diseases (16 papers) and Inflammatory Myopathies and Dermatomyositis (14 papers). M. Meurer is often cited by papers focused on Systemic Sclerosis and Related Diseases (24 papers), Autoimmune Bullous Skin Diseases (16 papers) and Inflammatory Myopathies and Dermatomyositis (14 papers). M. Meurer collaborates with scholars based in Germany, Hungary and United States. M. Meurer's co-authors include Otto Braun‐Falco, B Lehmann, Thomas Krieg, S A Bell, Gerd Plewig, W. Stolz, Jochen Schmitt, Jürgen Behr, Thomas Ruzicka and Claudia Günther and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

M. Meurer

97 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Meurer Germany	24	745	617	393	380	361	104	1.8k
Mark D. P. Davis United States	29	495 0.7×	711 1.2×	495 1.3×	203 0.5×	564 1.6×	85	2.3k
Jordi Peyrı́ Spain	22	347 0.5×	618 1.0×	554 1.4×	249 0.7×	206 0.6×	59	1.3k
Hong‐Shang Hong Taiwan	19	605 0.8×	693 1.1×	327 0.8×	227 0.6×	513 1.4×	67	2.4k
K. Tamaki Japan	16	267 0.4×	364 0.6×	234 0.6×	255 0.7×	539 1.5×	59	1.5k
Vicente García‐Patos Spain	23	332 0.4×	602 1.0×	741 1.9×	403 1.1×	419 1.2×	124	2.0k
Charles Camisa United States	28	1.1k 1.5×	757 1.2×	578 1.5×	399 1.1×	627 1.7×	116	2.7k
J.‐H. Saurat Switzerland	25	600 0.8×	908 1.5×	319 0.8×	927 2.4×	581 1.6×	77	2.3k
V. Descamps France	29	537 0.7×	672 1.1×	593 1.5×	646 1.7×	1.0k 2.9×	165	3.0k
D. Bessis France	27	393 0.5×	629 1.0×	421 1.1×	335 0.9×	480 1.3×	182	2.2k
Miklós Sárdy Hungary	27	1.0k 1.4×	563 0.9×	454 1.2×	293 0.8×	691 1.9×	126	2.3k

Countries citing papers authored by M. Meurer

Since Specialization

Citations

This map shows the geographic impact of M. Meurer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Meurer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Meurer more than expected).

Fields of papers citing papers by M. Meurer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Meurer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Meurer. The network helps show where M. Meurer may publish in the future.

Co-authorship network of co-authors of M. Meurer

This figure shows the co-authorship network connecting the top 25 collaborators of M. Meurer. A scholar is included among the top collaborators of M. Meurer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Meurer. M. Meurer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Macagno, Nicolas, Laurent Greillier, M.‐A. Richard, et al.. (2023). Étude de cohorte évaluant la toxicité cutanée des anticorps bispécifiques anti-EGFR et anti-MET seuls ou en association aux inhibiteurs d’EGFR. 3(8). A145–A145.

Meurer, M.. (2009). Pemphiguserkrankungen bei Kindern und Jugendlichen. Der Hautarzt. 60(3). 208–216. 3 indexed citations

Hunzelmann, Nicolas, E. Genth, Thomas Krieg, et al.. (2008). Organspezifische Diagnostik von Patienten mit systemischer Sklerodermie. Zeitschrift für Rheumatologie. 67(4). 334–340. 13 indexed citations

Schmitt, Jochen, Ulf Maywald, N. Schmitt, M. Meurer, & Wilhelm Kirch. (2008). Cardiovascular Risk Factors and Psychiatric Comorbidity in Patients with Atopic Eczema: A Population-Based Case-Control Study. Dermatitis. 19(4). 218–238. 3 indexed citations

Meurer, M., et al.. (2007). Therapie bei systemischer Sklerodermie. Der Hautarzt. 58(10). 851–857. 3 indexed citations

Spornraft‐Ragaller, Petra, Christian Lück, Eduardo G. Moros, & M. Meurer. (2006). Lymphogranuloma venereum. Der Hautarzt. 57(12). 1095–1100. 8 indexed citations

Lehmann, B, et al.. (2003). Demonstration of UVB-induced synthesis of 1α,25-dihydroxyvitamin D3 (calcitriol) in human skin by microdialysis. Archives of Dermatological Research. 295(1). 24–28. 70 indexed citations

Aschoff, Roland, Gottfried Wozel, & M. Meurer. (2003). Aktuelle Aspekte der topischen Psoriasisbehandlung. Der Hautarzt. 54(3). 237–241. 2 indexed citations

Schubert, Katja, Annette Stein, & M. Meurer. (2002). Initiales Skleromyxödem Erfolgreiche Therapie mit Melphalan. Der Hautarzt. 53(7). 478–482. 4 indexed citations

10.

Messer, Gerald, et al.. (2001). Pemphigus vegetans. Der Hautarzt. 52(6). 504–509. 9 indexed citations

11.

Behr, Jürgen, Claus Vogelmeier, T. Beinert, et al.. (1996). Bronchoalveolar Lavage for Evaluation and Management of Scleroderma Disease of the Lung. American Journal of Respiratory and Critical Care Medicine. 154(2). 400–406. 102 indexed citations

12.

Folwaczny, C, et al.. (1995). [Gastrointestinal involvement in progressive systemic scleroderma].. PubMed. 33(11). 654–61. 4 indexed citations

13.

Kerscher, Martina, Matthias Volkenandt, M. Meurer, et al.. (1994). PUVA-bath-photochemotherapy of localized scleroderma. Journal of Investigative Dermatology. 103(3). 434. 13 indexed citations

14.

Bell, S A, Korbinian Brand, & M. Meurer. (1992). [Toxic oil syndrome--an example of an exogenously-induced autoimmune disease].. PubMed. 43(6). 339–43. 3 indexed citations

15.

Członkowska, Anna, et al.. (1992). Anticardiolipin Antibodies: Clinical Characteristics of Antibody-Positive Patients with Recent Cerebrovascular Events. Cerebrovascular Diseases. 2(5). 301–304. 5 indexed citations

16.

Hein, R., Jürgen Behr, Nicolas Hunzelmann, et al.. (1992). Treatment of systemic sclerosis with γ-interferon. British Journal of Dermatology. 126(5). 496–501. 61 indexed citations

17.

Przybilla, Bernhard, et al.. (1992). Acute mercury intoxication with lichenoid drug eruption followed by mercury contact allergy and development of antinuclear antibodies.. Acta Dermato Venereologica. 72(4). 294–296. 29 indexed citations

18.

Schulze, Eric, M Heckmann, Ingo Schubert, et al.. (1990). Type III collagen aminopropeptide and laminin PI levels in serum of patients with silicosis-associated and idiopathic systemic scleroderma. British Journal of Dermatology. 123(1). 1–7. 12 indexed citations

19.

Kárpáti, Sarolta, et al.. (1989). Jejunal and endomysium antibody in dermatitis herpetiformis and in coeliac disease. Journal of Investigative Dermatology. 93(2). 301. 1 indexed citations

20.

Meurer, M., et al.. (1989). Soluble II-2 receptor serum levels ? a marker for disease progression in patients with HIV-1 infection. Archives of Dermatological Research. 281(5). 299–303. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact